Moderators of ayahuasca's biological antidepressant actionFRONTIERS IN PSYCHIATRYIF3.22022-12-056OAAI
Suicide by jumping from high places in a Brazilian city: regional peculiarities as a determining factor of variation in suicide methodsBRAZILIAN JOURNAL OF PSYCHIATRYIF2.62019-10-011OAAI
Acute effects of ayahuasca in a juvenile non-human primate model of depressionBRAZILIAN JOURNAL OF PSYCHIATRYIF2.62019-08-0134OAAI
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial迷幻的ayahuasca在难治性抑郁症中的快速抗抑郁作用: 一项随机安慰剂对照试验PSYCHOLOGICAL MEDICINEIF5.52018-06-15341OAAI
An Overview of Animal Models Related to SchizophreniaCANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIEIF3.82018-05-09169OAAI
Cortisol Modulation by Ayahuasca in Patients With Treatment Resistant Depression and Healthy ControlsFRONTIERS IN PSYCHIATRYIF3.22018-05-0878OAAI
Letter to the Editor Sodium nitroprusside for schizophrenia: could methodological variables account for the different results obtained?PSYCHOLOGICAL MEDICINEIF5.52016-12-096OAAI
Nitric Oxide's Involvement in the Spectrum of Psychotic DisordersCURRENT MEDICINAL CHEMISTRYIF3.52016-08-3013PRE
Cognition in at-risk mental states for psychosisNEUROSCIENCE AND BIOBEHAVIORAL REVIEWSIF7.92015-10-0133PREAI
Nitroprusside single-dose prevents the psychosis-like behavior induced by ketamine in rats for up to one weekSCHIZOPHRENIA RESEARCHIF3.52015-03-0125OAAI
Effects of minocycline add-on treatment on brain morphometry and cerebral perfusion in recent-onset schizophreniaSCHIZOPHRENIA RESEARCHIF3.52015-02-0134PREAI
Sodium nitroprusside, a nitric oxide donor for novel treatment of schizophrenia, may also modulate dopaminergic systemsSCHIZOPHRENIA RESEARCHIF3.52014-11-0112PREAI
Minocycline and psychoneuroimmunology in schizophreniaPROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRYIF3.92010-08-012PREAI
Functional neuroimaging of minocycline's effect in a patient with schizophreniaPROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRYIF3.92010-04-0123PREAI